Literature DB >> 12654361

Clinicopathologic correlation and genetic analysis in a case of posterior polymorphous corneal dystrophy.

Sayoko E Moroi1, Parag A Gokhale, Miriam T Schteingart, Alan Sugar, Catherine A Downs, Satoko Shimizu, Charles Krafchak, Nobuo Fuse, Susan G Elner, Victor M Elner, Andrew Flint, Michael P Epstein, Michael Boehnke, Julia E Richards.   

Abstract

PURPOSE: To evaluate the clinical history, histopathology, and genetics of posterior polymorphous corneal dystrophy (PPMD) in a woman with a prominent retrocorneal membrane.
DESIGN: Observational case report and genetic analysis of her family, UM:139.
METHODS: Records were reviewed from a case and associated family members. The diagnosis of PPMD was based on clinical examination, immunohistochemical staining, electron microscopy, and screening of genetic markers from regions previously reported to be associated with PPMD.
RESULTS: Over 17 years, the proband with PPMD had 25 ocular procedures performed for glaucoma, cataract, cornea, retina, and postoperative problems. A prominent retrocorneal membrane grew onto the crystalline lens and intraocular lens (IOL). Histopathology revealed stratified epithelial-like cells on iris from an iridectomy and stratified corneal endothelium on a corneal button. Electron microscopy on the cornea revealed microvilli, tonofilaments, and desmosomes consistent with endothelial transformation, which was confirmed by positive anticytokeratin (CK) AE1/AE3 and CAM 5.2 immunoreactivity. Negative immunoreactivity in epithelium and positive in endothelium with anti-CK 7 supported the diagnosis of PPMD rather than epithelial downgrowth. Multiple relatives were affected with PPMD with apparent autosomal dominant inheritance, but surprisingly, the PPMD, congenital hereditary endothelial dystrophy 1 (CHED1) and CHED2 loci on chromosome 20 and the collagen, type VIII, alpha-2 (COL8A2) gene were excluded by linkage and haplotype analyses.
CONCLUSIONS: We are unaware of previous PPMD reports describing the unusual feature of a retrocorneal membrane extending onto the crystalline lens and IOL. In addition, this family suggests another PPMD locus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654361     DOI: 10.1016/s0002-9394(02)02032-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10.

Authors:  Satoko Shimizu; Charles Krafchak; Nobuo Fuse; Michael P Epstein; Miriam T Schteingart; Alan Sugar; Maya Eibschitz-Tsimhoni; Catherine A Downs; Frank Rozsa; Edward H Trager; David M Reed; Michael Boehnke; Sayoko E Moroi; Julia E Richards
Journal:  Am J Med Genet A       Date:  2004-11-01       Impact factor: 2.802

2.  Zeb1 mutant mice as a model of posterior corneal dystrophy.

Authors:  Yongqing Liu; Xiaoyan Peng; Jinlian Tan; Douglas S Darling; Henry J Kaplan; Douglas C Dean
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

3.  Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells.

Authors:  Charles M Krafchak; Hemant Pawar; Sayoko E Moroi; Alan Sugar; Paul R Lichter; David A Mackey; Shahzad Mian; Theresa Nairus; Victor Elner; Miriam T Schteingart; Catherine A Downs; Theresa Guckian Kijek; Jenae M Johnson; Edward H Trager; Frank W Rozsa; Md Nawajes Ali Mandal; Michael P Epstein; Douglas Vollrath; Radha Ayyagari; Michael Boehnke; Julia E Richards
Journal:  Am J Hum Genet       Date:  2005-09-14       Impact factor: 11.025

4.  Recurrence of posterior polymorphous corneal dystrophy is caused by the overgrowth of the original diseased host endothelium.

Authors:  Stanislava Merjava; Eva Malinova; Petra Liskova; Martin Filipec; Zuzana Zemanova; Kyra Michalova; Katerina Jirsova
Journal:  Histochem Cell Biol       Date:  2011-06-22       Impact factor: 4.304

5.  The OV-TL 12/30 clone of anti-cytokeratin 7 antibody as a new marker of corneal conjunctivalization in patients with limbal stem cell deficiency.

Authors:  Katerina Jirsova; Lubica Dudakova; Sarka Kalasova; Viera Vesela; Stanislava Merjava
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

6.  Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population.

Authors:  Andrea L Vincent; Rachael L Niederer; Amanda Richards; Betina Karolyi; Dipika V Patel; Charles N J McGhee
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

7.  The PPCD1 mouse: characterization of a mouse model for posterior polymorphous corneal dystrophy and identification of a candidate gene.

Authors:  Anna L Shen; Kathleen A O'Leary; Richard R Dubielzig; Norman Drinkwater; Christopher J Murphy; Charles B Kasper; Christopher A Bradfield
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

8.  Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3.

Authors:  Petra Liskova; Cerys J Evans; Alice E Davidson; Marketa Zaliova; Lubica Dudakova; Marie Trkova; Viktor Stranecky; Nicole Carnt; Vincent Plagnol; Andrea L Vincent; Stephen J Tuft; Alison J Hardcastle
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

9.  Spatiotemporally Controlled Ablation of Klf5 Results in Dysregulated Epithelial Homeostasis in Adult Mouse Corneas.

Authors:  Chelsea L Loughner; Anil Tiwari; Doreswamy Kenchegowda; Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

10.  Analysis of SLC4A11, ZEB1, LOXHD1, COL8A2 and TCF4 gene sequences in a multi-generational family with late-onset Fuchs corneal dystrophy.

Authors:  Hui Tang; Wen Zhang; Xin-Min Yan; Lin-Ping Wang; Hong Dong; Tao Shou; Huo Lei; Qiang Guo
Journal:  Int J Mol Med       Date:  2016-04-20       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.